Correlation Between Ultrashort Mid-cap and Biotechnology Ultrasector

Can any of the company-specific risk be diversified away by investing in both Ultrashort Mid-cap and Biotechnology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultrashort Mid-cap and Biotechnology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ultrashort Mid Cap Profund and Biotechnology Ultrasector Profund, you can compare the effects of market volatilities on Ultrashort Mid-cap and Biotechnology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultrashort Mid-cap with a short position of Biotechnology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultrashort Mid-cap and Biotechnology Ultrasector.

Diversification Opportunities for Ultrashort Mid-cap and Biotechnology Ultrasector

0.04

Correlation Coefficient

Ultrashort Mid-cap  Biotechnology Ultrasector

Significant diversification

The 3 months correlation between Ultrashort and Biotechnology is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Ultrashort Mid Cap Profund and Biotechnology Ultrasector Prof in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Ultrasector and Ultrashort Mid-cap is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultrashort Mid Cap Profund are associated (or correlated) with Biotechnology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Ultrasector has no effect on the direction of Ultrashort Mid-cap i.e., Ultrashort Mid-cap and Biotechnology Ultrasector go up and down completely randomly.

Pair Corralation between Ultrashort Mid-cap and Biotechnology Ultrasector

Assuming the 90 days horizon Ultrashort Mid Cap Profund is expected to under-perform the Biotechnology Ultrasector. But the mutual fund apears to be less risky and, when comparing its historical volatility, Ultrashort Mid Cap Profund is 1.1 times less risky than Biotechnology Ultrasector. The mutual fund trades about -0.17 of its potential returns per unit of risk. The Biotechnology Ultrasector Profund is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  6,846  in Biotechnology Ultrasector Profund on September 2, 2024 and sell it today you would earn a total of  49.00  from holding Biotechnology Ultrasector Profund or generate 0.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ultrashort Mid Cap Profund  vs.  Biotechnology Ultrasector Prof

Ultrashort Mid Cap

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ultrashort Mid Cap Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Biotechnology Ultrasector

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Ultrasector Profund are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Biotechnology Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Ultrashort Mid-cap and Biotechnology Ultrasector

The main advantage of trading using opposite Ultrashort Mid-cap and Biotechnology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultrashort Mid-cap position performs unexpectedly, Biotechnology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will offset losses from the drop in Biotechnology Ultrasector's long position.

The idea behind Ultrashort Mid Cap Profund and Biotechnology Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.